Literature DB >> 21435330

Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study.

C Savulescu1, S Jiménez-Jorge, S de Mateo, J Ledesma, F Pozo, I Casas, A Larrauri.   

Abstract

We present preliminary results of a case-control study to estimate influenza vaccine effectiveness in Spain, from week 50 of 2010 to week 6 of 2011. The adjusted effectiveness of the vaccine in preventing laboratory-confirmed influenza due to any type of influenza virus was 50% (95% CI: -6 to 77%) for the trivalent seasonal vaccine and 72% (95% CI: 7 to 92%) for both trivalent seasonal and monovalent pandemic vaccines, suggesting a protective effect of seasonal vaccination lower than that reported for the previous season.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21435330     DOI： 10.2807/ese.16.11.19820-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  10 in total

Review 1.  Influenza virus vaccines: lessons from the 2009 H1N1 pandemic.

Authors:  Andrew J Broadbent; Kanta Subbarao
Journal:  Curr Opin Virol       Date:  2011-10       Impact factor: 7.090

2.  Influenza vaccine effectiveness estimates in Croatia in 2010-2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus.

Authors:  S Kurečić Filipović; I Gjenero-Margan; E Kissling; B Kaić; A Cvitković
Journal:  Epidemiol Infect       Date:  2015-01-08       Impact factor: 4.434

3.  Predicting AH1N1 2009 influenza epidemic in Southeast Europe.

Authors:  Mladen Smoljanović; Ankica Smoljanović; Marijana Mlikotić
Journal:  Croat Med J       Date:  2011-04-15       Impact factor: 1.351

4.  Long-term respiratory follow-up of H1N1 infection.

Authors:  Paul Zarogoulidis; George Kouliatsis; Nikolaos Papanas; Dionysis Spyratos; Theodoros C Constantinidis; Ioannis Kouroumichakis; Paschalis Steiropoulos; Maria Mabroudi; Dimitris Matthaios; Theodora Kerenidi; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis; Efstratios Maltezos
Journal:  Virol J       Date:  2011-06-25       Impact factor: 4.099

5.  I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe.

Authors:  Esther Kissling; Marta Valenciano; Jean Marie Cohen; Beatrix Oroszi; Anne-Sophie Barret; Caterina Rizzo; Pawel Stefanoff; Baltazar Nunes; Daniela Pitigoi; Amparo Larrauri; Isabelle Daviaud; Judit Krisztina Horvath; Joan O'Donnell; Thomas Seyler; Iwona Anna Paradowska-Stankiewicz; Pedro Pechirra; Alina Elena Ivanciuc; Silvia Jiménez-Jorge; Camelia Savulescu; Bruno Christian Ciancio; Alain Moren
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

6.  Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.

Authors:  Silvia Jiménez-Jorge; Salvador de Mateo; Concha Delgado-Sanz; Francisco Pozo; Inmaculada Casas; Manuel Garcia-Cenoz; Jesús Castilla; Esteban Pérez; Virtudes Gallardo; Carolina Rodriguez; Tomás Vega; Carmen Quiñones; Eva Martínez; Juana María Vanrell; Jaume Giménez; Daniel Castrillejo; María del Carmen Serrano; Julián Mauro Ramos; Amparo Larrauri
Journal:  BMC Infect Dis       Date:  2013-09-22       Impact factor: 3.090

Review 7.  The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis.

Authors:  Lauren C Ramsay; Sarah A Buchan; Robert G Stirling; Benjamin J Cowling; Shuo Feng; Jeffrey C Kwong; Bryna F Warshawsky
Journal:  BMC Med       Date:  2017-08-21       Impact factor: 8.775

8.  Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain.

Authors:  Alin Gherasim; Iván Martínez-Baz; Jesús Castilla; Francisco Pozo; Amparo Larrauri
Journal:  PLoS One       Date:  2017-06-14       Impact factor: 3.240

9.  Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach.

Authors:  Angelia A Eick-Cost; Katie J Tastad; Alicia C Guerrero; Matthew C Johns; Seung-Eun Lee; Victor H Macintosh; Ronald L Burke; David L Blazes; Kevin L Russell; Jose L Sanchez
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

10.  Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.

Authors:  Enrique Alcalde-Cabero; Javier Almazán-Isla; Fernando J García López; José Ramón Ara-Callizo; Fuencisla Avellanal; Carlos Casasnovas; Carlos Cemillán; José Ignacio Cuadrado; Jacinto Duarte; María Dolores Fernández-Pérez; Óscar Fernández; Juan Antonio García Merino; Rosa García Montero; Dolores Montero; Julio Pardo; Francisco Javier Rodríguez-Rivera; María Ruiz-Tovar; Jesús de Pedro-Cuesta
Journal:  BMC Neurol       Date:  2016-05-21       Impact factor: 2.474
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.